XR5118, a novel modulator of plasminogen activator inhibitor-1 (PAI-1), increases endogenous tPA activity in the rat

This publication has 14 references indexed in Scilit:

• Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro.
  Journal of Clinical Investigation, 1995
• Conformational Studies on Plasminogen Activator Inhibitor (PAI-1) in Active, Latent, Substrate, and Cleaved Forms
  Biochemistry, 1995
• Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets
  Thrombosis Research, 1993
• Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.
  Journal of Clinical Investigation, 1993
• The potential role of platelet PAI-1 in t-PA mediated clot lysis of platelet rich plasma
  Thrombosis Research, 1993
• Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients.
  Heart, 1993
• The status of PAI-1 as a risk factor for arterial and thrombotic disease: A review
  Atherosclerosis, 1992
• Plasminogen Activator Inhibitor Type 1: Biochemistry and Evidence for Modulation of Fibrinolysis In Vivo
  Seminars in Thrombosis and Hemostasis, 1992
• Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene
  Nature, 1990